RET
Summary: This gene encodes a transmembrane receptor and member of the tyrosine protein kinase family of proteins. Binding of ligands such as GDNF (glial cell-line derived neurotrophic factor) and other related proteins to the encoded receptor stimulates receptor dimerization and activation of downstream signaling pathways that play a role in cell differentiation, growth, migration and survival. The encoded receptor is important in development of the nervous system, and the development of organs and tissues derived from the neural crest. This proto-oncogene can undergo oncogenic activation through both cytogenetic rearrangement and activating point mutations. Mutations in this gene are associated with Hirschsprung disease and central hypoventilation syndrome and have been identified in patients with renal agenesis. [provided by RefSeq, Sep 2017].
Name | OMIM ID | Ensembl ID | HGNC ID | PHARMGKB ID | Map Location |
---|---|---|---|---|---|
ret proto-oncogene | MIM:164761 | Ensembl:ENSG00000165731 | HGNC:HGNC:9967 | PA34335 | 10q11.21 |
GO terms in RET
Term Type | Evidence Type | GO Term ID | GO Des. |
---|---|---|---|
BP | TAS | GO:0000165 | MAPK cascade |
BP | IMP | GO:0000187 | activation of MAPK activity |
BP | IEA | GO:0001657 | ureteric bud development |
BP | IEA | GO:0001755 | neural crest cell migration |
BP | IEA | GO:0001838 | embryonic epithelial tube formation |
BP | TAS | GO:0006468 | protein phosphorylation |
BP | IEA | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules |
BP | IMP | GO:0007158 | neuron cell-cell adhesion |
BP | TAS | GO:0007165 | signal transduction |
BP | IBA | GO:0007275 | multicellular organism development |
BP | TAS | GO:0007411 | axon guidance |
BP | TAS | GO:0007497 | posterior midgut development |
BP | IBA | GO:0009968 | negative regulation of signal transduction |
BP | IMP | GO:0010976 | positive regulation of neuron projection development |
BP | IEA | GO:0014042 | positive regulation of neuron maturation |
BP | IEA | GO:0018108 | peptidyl-tyrosine phosphorylation |
BP | IBA | GO:0030154 | cell differentiation |
BP | IDA | GO:0030155 | regulation of cell adhesion |
BP | IDA | GO:0030335 | positive regulation of cell migration |
BP | IEA | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein |
BP | IDA | GO:0033619 | membrane protein proteolysis |
BP | IDA | GO:0033630 | positive regulation of cell adhesion mediated by integrin |
BP | IBA | GO:0033674 | positive regulation of kinase activity |
BP | IEA | GO:0035799 | ureter maturation |
BP | IDA | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway |
BP | IEA | GO:0042493 | response to drug |
BP | IEA | GO:0042551 | neuron maturation |
BP | IBA | GO:0043066 | negative regulation of apoptotic process |
BP | IDA | GO:0043410 | positive regulation of MAPK cascade |
BP | IEA | GO:0045793 | positive regulation of cell size |
BP | ISS | GO:0045893 | positive regulation of transcription, DNA-templated |
BP | ISS | GO:0048265 | response to pain |
BP | IEA | GO:0048484 | enteric nervous system development |
BP | IEA | GO:0050770 | regulation of axonogenesis |
BP | IMP | GO:0051897 | positive regulation of protein kinase B signaling |
BP | IEA | GO:0060041 | retina development in camera-type eye |
BP | IEA | GO:0060384 | innervation |
BP | ISS | GO:0061146 | Peyer's patch morphogenesis |
BP | IBA | GO:0070374 | positive regulation of ERK1 and ERK2 cascade |
BP | IMP | GO:0071300 | cellular response to retinoic acid |
BP | ISS | GO:0072300 | positive regulation of metanephric glomerulus development |
BP | ISS | GO:0097021 | lymphocyte migration into lymphoid organs |
BP | TAS | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand |
CC | IBA | GO:0005737 | cytoplasm |
CC | IEA | GO:0005769 | early endosome |
CC | IDA | GO:0005829 | cytosol |
CC | IDA | GO:0005886 | plasma membrane |
CC | TAS | GO:0005886 | plasma membrane |
CC | IBA | GO:0005887 | integral component of plasma membrane |
CC | IDA | GO:0005887 | integral component of plasma membrane |
CC | IDA | GO:0010008 | endosome membrane |
CC | IBA | GO:0030424 | axon |
CC | IEA | GO:0030424 | axon |
CC | IEA | GO:0030425 | dendrite |
CC | IEA | GO:0043025 | neuronal cell body |
CC | IDA | GO:0043231 | intracellular membrane-bounded organelle |
CC | IBA | GO:0043235 | receptor complex |
CC | IDA | GO:0043235 | receptor complex |
CC | IEA | GO:0045121 | membrane raft |
CC | IDA | GO:0098797 | plasma membrane protein complex |
MF | IBA | GO:0004709 | MAP kinase kinase kinase activity |
MF | IBA | GO:0004713 | protein tyrosine kinase activity |
MF | TAS | GO:0004713 | protein tyrosine kinase activity |
MF | IBA | GO:0004714 | transmembrane receptor protein tyrosine kinase activity |
MF | IDA | GO:0004714 | transmembrane receptor protein tyrosine kinase activity |
MF | TAS | GO:0004714 | transmembrane receptor protein tyrosine kinase activity |
MF | IBA | GO:0004888 | transmembrane signaling receptor activity |
MF | TAS | GO:0005088 | Ras guanyl-nucleotide exchange factor activity |
MF | IDA | GO:0005509 | calcium ion binding |
MF | IPI | GO:0005515 | protein binding |
MF | IEA | GO:0005524 | ATP binding |
MF | IBA | GO:0031434 | mitogen-activated protein kinase kinase binding |
MF | TAS | GO:0038023 | signaling receptor activity |
Gene expression in normal tissue: RET
Gene-model tissue-cancer distribution: Bubble Plot
Gene-drug pathway distribution
Pathways in RET
Database | Pathway ID | Pathway Des. |
---|---|---|
reactome | R-HSA-1266738 | Developmental Biology |
reactome | R-HSA-162582 | Signal Transduction |
reactome | R-HSA-422475 | Axon guidance |
reactome | R-HSA-5673001 | RAF/MAP kinase cascade |
reactome | R-HSA-5683057 | MAPK family signaling cascades |
reactome | R-HSA-5684996 | MAPK1/MAPK3 signaling |
reactome | R-HSA-8853659 | RET signaling |
pid | ajdiss_2pathway | Posttranslational regulation of adherens junction stability and dissassembly |
pid | ret_pathway | Signaling events regulated by Ret tyrosine kinase |
kegg | hsa05200 | Pathways in cancer - Homo sapiens (human) |
kegg | hsa05216 | Thyroid cancer - Homo sapiens (human) |
kegg | hsa05230 | Central carbon metabolism in cancer - Homo sapiens (human) |
pharmgkb | PA165959425 | Pathway_PA165959425 |
pharmgkb | PA165959584 | Sorafenib Pharmacodynamics |
wikipathways | WP2586 | Aryl Hydrocarbon Receptor |
wikipathways | WP2855 | Dopaminergic Neurogenesis |
wikipathways | WP706 | Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways |
Gene-Drug: Aster Plot
Drug ID | Drug Name | Model Num. |
---|---|---|
iGMDRD999 | RET inhibitor | 4 |
iGMDRD116 | CD437 | 3 |
iGMDRD770 | Hydroxy Vandetanib | 1 |
iGMDRD512 | nutlin 3 | 4 |
iGMDRD330 | BRD4132 | 3 |
iGMDRD307 | Manumycin A | 6 |
iGMDRD945 | ML214 | 3 |
iGMDRD132 | (-)-gallocatechin-3-O-gallate | 4 |
iGMDRD240 | Vandetanib | 10 |
iGMDRD499 | PDMP | 6 |
iGMDRD85 | Ursolic acid | 3 |
iGMDRD341 | Triacsin c | 1 |
iGMDRD267 | Oligomycin A | 1 |
iGMDRD415 | LE-135 | 3 |
iGMDRD434 | BMS-536924 | 2 |
iGMDRD241 | Sunitinib | 3 |
iGMDRD289 | Parthenolide | 3 |
iGMDRD221 | Tamoxifen | 3 |
iGMDRD467 | Motesanib | 2 |
iGMDRD5 | Tyrphostin AG 1478 | 3 |
iGMDRD137 | Indisulam | 2 |
iGMDRD158 | NSC141540 | 3 |
iGMDRD271 | Brefeldin A | 3 |
iGMDRD202 | Curcumin | 3 |
iGMDRD82 | Quiflapon | 6 |
iGMDRD300 | Tozasertib | 6 |
iGMDRD872 | BRD7137 | 3 |
iGMDRD882 | CIL41 | 3 |
iGMDRD286 | Nsc 632839 | 3 |
iGMDRD871 | BRD6368 | 3 |
iGMDRD427 | ABT737 | 2 |
iGMDRD144 | NSC95397 | 2 |
iGMDRD772 | BRD4770 | 6 |
iGMDRD889 | Compound 7d-cis | 3 |
iGMDRD599 | Salermide | 6 |
iGMDRD571 | Cabozantinib | 2 |
iGMDRD502 | AZD1480 | 1 |
iGMDRD126 | Tipifarnib | 2 |
iGMDRD280 | CYTOCHALASIN B | 3 |
iGMDRD52 | Rotenone | 3 |
iGMDRD187 | BRD9876 | 3 |
iGMDRD885 | Compound 110 | 3 |
iGMDRD441 | TW 37 | 3 |
iGMDRD318 | PAC-1 | 3 |
iGMDRD782 | DC-45-A2 | 4 |
iGMDRD171 | Pemetrexed | 6 |
iGMDRD134 | Sorafenib | 1 |
iGMDRD138 | PX 12 | 3 |
iGMDRD474 | Avrainvillamide | 3 |
iGMDRD270 | Ciclosporin | 1 |
iGMDRD524 | ISX-9 | 3 |
iGMDRD690 | PRIMA-1MET | 3 |
iGMDRD780 | PP-30 | 3 |
iGMDRD887 | Compound 23 citrate | 1 |
iGMDRD188 | Piperlongumine | 1 |
Gene in drug-gene network: Network Plot
Gene-drug targets distribution
Gene Structure: PDB
Models in RET